The purpose of this trial is to assess whether the Stabilimax NZ™ is at least as safe and effective as the control therapy of fusion in patients receiving decompression surgery for the treatment of clinically symptomatic spinal stenosis at one or two contiguous vertebral levels from L1-S1.  Safety and effectiveness will be assessed by means of primary study endpoints which address improvements in pain and function in the absence of major device related complications.

Call Crystal Hill, CCRC at (919) 281-1870.

chill@triangleortho.com